InterventionsHumans73,138 participants1 yearCohort study

Vagal activity related events and glucagon-like peptide-1 receptor agonists

European Heart Journal Cardiovascular Pharmacotherapy

The paper

Lina Al-Ansary, Sebastian Kinnberg Nielsen, Mads Hashiba Jensen,

Nina Nouhravesh, Caroline Sindet‐Pedersen, Gunnar Gislason, Peter Vibe Rasmussen, Morten Lamberts,

Herlev Hospital

European Heart Journal Cardiovascular Pharmacotherapy · 8 Sep 2026

doi.org/10.1093/ehjcvp/pvag072 PubMed 42709513

Diabetes drug class linked to slightly less frailty progression
Diabetes, Obesity & Metabolism · 8 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Lancet · 4 Oct 2026